药易购
(300937)
| 流通市值：17.55亿 | | | 总市值：26.81亿 |
| 流通股本：6264.74万 | | | 总股本：9566.67万 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,137,614,693.12 | 4,380,809,520.01 | 3,235,469,610.27 | 2,225,319,754.46 |
| 营业收入 | 1,137,614,693.12 | 4,380,809,520.01 | 3,235,469,610.27 | 2,225,319,754.46 |
| 二、营业总成本 | 1,120,320,821.96 | 4,346,174,702.44 | 3,211,095,776.4 | 2,201,464,225.02 |
| 营业成本 | 1,011,930,212.47 | 3,990,533,313.19 | 2,956,968,916.08 | 2,039,797,580.23 |
| 税金及附加 | 2,245,916.74 | 8,866,486.16 | 5,808,090.97 | 3,792,390.96 |
| 销售费用 | 84,234,538.85 | 251,435,378.16 | 180,912,080.87 | 112,209,368.32 |
| 管理费用 | 16,560,922.61 | 70,980,183.23 | 48,263,363.14 | 32,240,316.64 |
| 研发费用 | 2,770,134.22 | 15,467,329.87 | 12,565,314.67 | 9,322,429.66 |
| 财务费用 | 2,579,097.07 | 8,892,011.83 | 6,578,010.67 | 4,102,139.21 |
| 其中:利息费用 | 2,470,053.97 | 9,710,490.08 | 7,392,613.53 | 5,082,217.33 |
| 其中:利息收入 | 653,293.93 | 3,872,883.43 | 3,182,109.29 | 2,486,590.36 |
| 加:投资收益 | 441,202.7 | -1,835,026.32 | -468,072.44 | -394,329.92 |
| 资产处置收益 | -1,927.82 | -606,269.06 | -496,970.1 | -598,652.61 |
| 资产减值损失(新) | -1,764,225.83 | -9,929,815.75 | 816,311.42 | 684,534.6 |
| 信用减值损失(新) | -10,352,278.65 | -7,896,914.22 | -15,381,890.49 | -16,141,199.06 |
| 其他收益 | 335,999.59 | 2,012,202.99 | 1,391,409.14 | 1,118,871.15 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 5,952,641.15 | 16,378,995.21 | 10,234,621.4 | 8,524,753.6 |
| 加:营业外收入 | 109,027.77 | 2,103,695.06 | 917,395.36 | 801,529.23 |
| 减:营业外支出 | 176,314.79 | 1,305,960.79 | 770,923.93 | 494,303.74 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 5,885,354.13 | 17,176,729.48 | 10,381,092.83 | 8,831,979.09 |
| 减:所得税费用 | 1,641,829.3 | 1,776,820.86 | -92,078.43 | -1,159,398.97 |
| 六、净利润 | 4,243,524.83 | 15,399,908.62 | 10,473,171.26 | 9,991,378.06 |
| 持续经营净利润 | 4,243,524.83 | 15,399,908.62 | 10,473,171.26 | 9,991,378.06 |
| 归属于母公司股东的净利润 | 4,183,729.42 | 16,358,248.01 | 13,931,460.39 | 12,095,746.45 |
| 少数股东损益 | 59,795.41 | -958,339.39 | -3,458,289.13 | -2,104,368.39 |
| (一)基本每股收益 | 0.04 | 0.17 | 0.15 | 0.13 |
| (二)稀释每股收益 | 0.04 | 0.17 | 0.15 | 0.13 |
| 九、综合收益总额 | 4,243,524.83 | 15,399,908.62 | 10,473,171.26 | 9,991,378.06 |
| 归属于母公司股东的综合收益总额 | 4,183,729.42 | 16,358,248.01 | 13,931,460.39 | 12,095,746.45 |
| 归属于少数股东的综合收益总额 | 59,795.41 | -958,339.39 | -3,458,289.13 | -2,104,368.39 |
| 公告日期 | 2025-04-25 | 2025-04-11 | 2024-10-25 | 2024-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |